
98PImplications for UK practice of the use of durvalumab in stage III NSCLC
Iqbal, M S, Atherton, P, Macgregor, C, Wieczorek, A, Singer, J, Walther, J, Little, F, Harden, S, Peedell, C, Cyriac, A, Chowdhury, S, Bayne, M, Yip, K, Britten, A, Powell, C, Brock, J, Datta, S, SeviVolume:
30
Langue:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz067.014
Date:
April, 2019
Fichier:
PDF, 77 KB
english, 2019